These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 30744686)

  • 61. The Place of Pharmacotherapy in Alcohol Use Disorder Management in Family Practice - A Systematic Review.
    Morgane GL; Delphine LG; Guillaume K; Yves LJ
    Curr Pharm Des; 2021; 27(23):2737-2745. PubMed ID: 33059563
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada.
    Konstantelos N; Tourchian N; McCormack D; Lecce P; Tadrous M; Gomes T
    Drug Alcohol Depend; 2023 Jan; 242():109705. PubMed ID: 36463765
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging approaches to managing alcohol dependence.
    Swift R
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S12-22. PubMed ID: 17322178
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Provider perspectives on emergency department initiation of medication assisted treatment for alcohol use disorder.
    Philippine T; Forsgren E; DeWitt C; Carter I; McCollough M; Taira BR
    BMC Health Serv Res; 2022 Apr; 22(1):456. PubMed ID: 35392901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patient Perspectives on Pharmacotherapy of Alcohol Dependence.
    Wellensiek J; Specka M; Just J; Banger M; Bonnet U; Scherbaum N
    Pharmacopsychiatry; 2024 Jan; 57(1):21-29. PubMed ID: 38052239
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Implementation and analysis of a multifaceted intervention for alcohol use disorder from a single academic urban emergency department.
    Duvalyan E; Falade I; Fan W; Foe M; Mvemba A; Zussman JW; Geier C; LeSaint KT; Graglia S
    Acad Emerg Med; 2024 May; 31(5):456-462. PubMed ID: 38380769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption.
    Robinson S; Bowe T; Harris AH
    J Subst Abuse Treat; 2013; 45(5):475-7. PubMed ID: 23932227
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacotherapy of alcohol use disorders.
    Buonopane A; Petrakis IL
    Subst Use Misuse; 2005; 40(13-14):2001-20, 2043-8. PubMed ID: 16282090
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alcohol dependence and pharmacologic treatment. Introduction.
    McDonough KP
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S3-4. PubMed ID: 17322180
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recent developments in the pharmacotherapy of alcohol dependence.
    Schuckit MA
    J Consult Clin Psychol; 1996 Aug; 64(4):669-76. PubMed ID: 8803356
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector.
    Abraham AJ; Roman PM
    J Stud Alcohol Drugs; 2010 May; 71(3):460-6. PubMed ID: 20409441
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The efficacy of disulfiram for the treatment of alcohol use disorder.
    Jørgensen CH; Pedersen B; Tønnesen H
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1749-58. PubMed ID: 21615426
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
    Grant JE; Potenza MN; Kraus SW; Petrakis IL
    J Clin Psychiatry; 2017; 78(9):e1299-e1306. PubMed ID: 29345864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.